These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3899006)

  • 1. Efficacy of BMY-28142 in experimental bacteremia and meningitis caused by Escherichia coli and group B streptococci.
    Kim KS; Bayer AS
    Antimicrob Agents Chemother; 1985 Jul; 28(1):51-4. PubMed ID: 3899006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of cefmenoxime in experimental group B streptococcal bacteraemia and meningitis.
    Kim KS
    J Antimicrob Chemother; 1986 Feb; 17(2):239-44. PubMed ID: 3516964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of teicoplanin in experimental group B streptococcal bacteremia and meningitis.
    Kim KS; Hang JH; Bayer AS
    Chemotherapy; 1987; 33(3):177-82. PubMed ID: 2954777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of imipenem in experimental group B streptococcal bacteremia and meningitis.
    Kim KS
    Chemotherapy; 1985; 31(4):304-9. PubMed ID: 3896683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of cefmenoxime in experimental Escherichia coli bacteremia and meningitis.
    Kim KS
    Antimicrob Agents Chemother; 1985 Sep; 28(3):389-92. PubMed ID: 3907491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftriaxone therapy of group B streptococcal bacteraemia and meningitis in infant rats.
    Delaplane D; Yogev R; Shulman ST
    J Antimicrob Chemother; 1983 Jan; 11(1):69-73. PubMed ID: 6298176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic studies of cefepime (BMY 28142) in murine meningitis and pharmacokinetics in neonatal rats.
    Tsai YH; Bies M; Leitner F; Kessler RE
    Antimicrob Agents Chemother; 1990 May; 34(5):733-8. PubMed ID: 2360814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of cefotaxime and latamoxef for Escherichia coli bacteremia and meningitis in newborn rats.
    Kim KS; Manocchio M; Bayer AS
    Chemotherapy; 1984; 30(4):262-9. PubMed ID: 6086247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of antimicrobial therapy for experimental infections due to group B Streptococcus on mortality and clearance of bacteria.
    Kim KS
    J Infect Dis; 1987 Jun; 155(6):1233-41. PubMed ID: 3553349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cefotaxime, imipenem-cilastatin, ampicillin-gentamicin, and ampicillin-chloramphenicol in the treatment of experimental Escherichia coli bacteremia and meningitis.
    Kim KS
    Antimicrob Agents Chemother; 1985 Sep; 28(3):433-6. PubMed ID: 3907493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New cephalosporins cefotaxime, cefpimizole, BMY 28142, and HR 810 in experimental pneumococcal meningitis in rabbits.
    Täuber MG; Hackbarth CJ; Scott KG; Rusnak MG; Sande MA
    Antimicrob Agents Chemother; 1985 Mar; 27(3):340-2. PubMed ID: 3838872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of cefotaxime and ceftriaxone alone and in combination with penicillin, ampicillin and piperacillin against neonatal meningitis pathogens.
    Hoogkamp-Korstanje JA
    J Antimicrob Chemother; 1985 Sep; 16(3):327-34. PubMed ID: 3932295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone, and rocephin in experimental bacterial meningitis.
    Schaad UB; McCracken GH; Loock CA; Thomas ML
    J Infect Dis; 1981 Feb; 143(2):156-63. PubMed ID: 6260870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of human immunoglobulin and penicillin G in treatment of experimental group B streptococcal infection.
    Kim KS
    Pediatr Res; 1987 Mar; 21(3):289-92. PubMed ID: 3550675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of trimethoprim/sulfamethoxazole in experimental Escherichia coli bacteremia and meningitis.
    Kim KS; Anthony BF
    Chemotherapy; 1983; 29(6):428-35. PubMed ID: 6360577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial activity of BMY-28142, a novel broad-spectrum cephalosporin.
    Tomatsu K; Ando S; Masuyoshi S; Hirano M; Miyaki T; Kawaguchi H
    J Antibiot (Tokyo); 1986 Nov; 39(11):1584-91. PubMed ID: 3539901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diseases caused by group G beta-hemolytic streptococci].
    Füssle R; Lang U; Wurdinger T
    Dtsch Med Wochenschr; 1989 Mar; 114(12):461-3. PubMed ID: 2924700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type III group B streptococcal infections in mice: bacteremia and meningitis following oral inoculation.
    Lounsbery JL; Green LR; Furtado D
    Can J Microbiol; 1981 Nov; 27(11):1150-5. PubMed ID: 7032679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergy between penicillins and low concentrations of gentamicin in the killing of group B streptococci.
    Swingle HM; Bucciarelli RL; Ayoub EM
    J Infect Dis; 1985 Sep; 152(3):515-20. PubMed ID: 3897398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relapse during penicillin treatment of group B streptococcal meningitis.
    Dorand RD; Adams G
    J Pediatr; 1976 Aug; 89(2):188-90. PubMed ID: 781198
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.